References
- Aljebreen AM (2007). Clinico-pathological patterns of colorectal cancer in Saudi Arabia: younger with an advanced stage presentation. Saudi J Gastroenterol, 13, 84-87. https://doi.org/10.4103/1319-3767.32183
- Al-Madouj A, Hayder M, Al-Zahrani W, et al (2011). Cancer incidence report saudi arabia. Saudi Cancer Registry 2011. http://www.chs.gov.sa/Ar/HealthRecords/CancerRegistry/ Pages/CancerRegistryRecords.aspx
- Amin TT, Suleman W, Al Taissan AA, et al (2012). Patients’ profile, clinical presentations and histopathological features of colo-rectal cancer in Al Hassa region, Saudi Arabia. Asian Pac J Cancer Prev, 13, 211-6. https://doi.org/10.7314/APJCP.2012.13.1.211
- Beg S, Siraj AK, Prabhakaran S, et al (2015). Molecular markers and pathway analysis of colorectal carcinoma in the Middle East. Cancer. 121, 3799-808. https://doi.org/10.1002/cncr.29580
- Domingo E, Laiho P, Ollikainen M, et al (2004). BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J Med Genet, 41, 664-8. https://doi.org/10.1136/jmg.2004.020651
- el-Hazmi MA, al-Swailem AR, Warsy AS, et al (1995). Consanguinity among the Saudi Arabian population. J Med Genet, 32, 623-26. https://doi.org/10.1136/jmg.32.8.623
- Elsamany SA, Alzahrani AS, Mohamed MM, et al (2014). Clinico-pathological patterns and survival outcome of colorectal cancer in young patients: western Saudi Arabia experience. Asian Pac J Cancer Prev, 15, 5239-43. https://doi.org/10.7314/APJCP.2014.15.13.5239
- Iacopetta B, Grieu F (2000). Routine detection of the replication error phenotype in clinical tumor specimens using fluorescence-SSCP. Biotechniques, 28, 566-70.
- Iacopetta B, Grieu F, Amanuel B (2010). Microsatellite instability in colorectal cancer. Asia Pac J Clin Oncol, 6, 260-9. https://doi.org/10.1111/j.1743-7563.2010.01335.x
- Ibrahim EM, Zeeneldin AA, El-Khodary TR, et al (2008). Past, present and future of colorectal cancer in the Kingdom of Saudi Arabia. Saudi J Gastroenterol, 14, 178-82. https://doi.org/10.4103/1319-3767.43275
- Jarvinen HJ, Aarnio M, Mustonen H, et al (2000). Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterol, 118, 829-34. https://doi.org/10.1016/S0016-5085(00)70168-5
- Li WQ, Kawakami K, Ruszkiewicz A, et al (2006). BRAF mutations are associated with distinctive clinical, pathological and molecular features of colorectal cancer independently of microsatellite instability status. Mol Cancer, 5, 2. https://doi.org/10.1186/1476-4598-5-2
- Lynch HT, de la Chapelle A (2003). Hereditary colorectal cancer. N Engl J Med, 348, 919-32. https://doi.org/10.1056/NEJMra012242
- Lynch HT, Riley BD, Weissman SM, et al (2004). Hereditary nonpolyposis colorectal carcinoma (HNPCC) and HNPCClike families: Problems in diagnosis, surveillance, and management. Cancer, 100, 53-64. https://doi.org/10.1002/cncr.11912
- Marcus VA, Madlensky L, Gryfe R, et al (1999). Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors. Am J Surg Pathol, 23, 1248-55. https://doi.org/10.1097/00000478-199910000-00010
- Mosli MH, Al-Ahwal MS (2012). Colorectal cancer in the Kingdom of Saudi Arabia: need for screening. Asian Pac J Cancer Prev, 13, 3809-13. https://doi.org/10.7314/APJCP.2012.13.8.3809
- Nemati A, Rahmatabadi ZK, Fatemi A, Emami MH (2011). Hereditary non-polyposis colorectal cancer and familial colorectal cancer in central part of Iran, Isfahan. J Res Med Scien, 17, 67-73.
- Pinol V, Castells A, Andreu M, et al (2005). Gastrointestinal oncology group of the spanish gastroenterological association. accuracy of revised bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA, 293, 1986-94. https://doi.org/10.1001/jama.293.16.1986
- Richter A, Grieu F, Carrello A, et al (2013). A multisite blinded study for the detection of BRAF mutations in formalin-fixed, paraffin-embedded malignant melanoma. Sci Rep, 3, 1659. https://doi.org/10.1038/srep01659
- Samowitz WS, Curtin K, Lin HH, et al (2001). The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer. Gastroenterol, 121, 830-8. https://doi.org/10.1053/gast.2001.27996
- Schofield L, Watson N, Grieu F, et al (2009). Population-based detection of Lynch syndrome in young colorectal cancer patients using microsatellite instability as the initial test. Int J Cancer, 124, 1097-102. https://doi.org/10.1002/ijc.23863
- Schofield L, Grieu F, Amanuel B, et al (2014). Population-based screening for Lynch syndrome in Western Australia. Int J Cancer, 135, 1085-91. https://doi.org/10.1002/ijc.28744
- Siraj AK, Bu R, Prabhakaran S, et al (2014). A very low incidence of BRAF mutations in Middle Eastern colorectal carcinoma. Mol Cancer, 13, 168. https://doi.org/10.1186/1476-4598-13-168
- Siraj AK, Prabhakaran S, Bavi P, et al (2015). Prevalence of Lynch syndrome in a Middle Eastern population with colorectal cancer. Cancer, 121, 1762-71. https://doi.org/10.1002/cncr.29288
- Snowsill T, Huxley N, Hoyle M, et al (2015). A model-based assessment of the cost-utility of strategies to identify Lynch syndrome in early-onset colorectal cancer patients. BMC Cancer, 15, 313. https://doi.org/10.1186/s12885-015-1254-5
- Suraweera N, Duval A, Reperant M, et al (2002). Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR. Gastroenterolo, 123, 1804-11. https://doi.org/10.1053/gast.2002.37070
- Terdiman JP (2005). It is time to get serious about diagnosing Lynch syndrome (hereditary nonpolyposis colorectal cancer with defective DNA mismatch repair) in the general population. Gastroenterol, 129, 741-4. https://doi.org/10.1016/j.gastro.2005.06.033
- Umar A, Boland CR, Terdiman JP, et al (2004). Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst, 96, 261-8. https://doi.org/10.1093/jnci/djh034
- Ward RL, Hicks S, Hawkins NJ (2013). Population-based molecular screening for Lynch syndrome: implications for personalized medicine. J Clin Oncol, 31, 2554-2562. https://doi.org/10.1200/JCO.2012.46.8454
- Xicola RM, Llor X, Pons E, et al (2007). Gastrointestinal oncology group of the spanish gastroenterological association. performance of different microsatellite marker panels for detection of mismatch repair-deficient colorectal tumors. J Natl Cancer Inst, 99, 244-52. https://doi.org/10.1093/jnci/djk033
- Zeinalian M, Hashemzadeh-Chaleshtori M, Akbarpour MJ, et al (2015). Epidemioclinical feature of early-onset colorectal cancer at-risk for Lynch syndrome in central Iran. Asian Pac J Cancer Prev, 16, 4647-52. https://doi.org/10.7314/APJCP.2015.16.11.4647
Cited by
- A new hereditary colorectal cancer network in the Middle East and eastern mediterranean countries to improve care for high-risk families pp.1573-7292, 2017, https://doi.org/10.1007/s10689-017-0018-6
- Screening for Lynch syndrome in young Saudi colorectal cancer patients using microsatellite instability testing and next generation sequencing pp.1573-7292, 2017, https://doi.org/10.1007/s10689-017-0015-9
- Molecular characteristics of colorectal cancer in a Middle Eastern population in a single institution vol.38, pp.4, 2018, https://doi.org/10.5144/0256-4947.2018.251